These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 28864645

  • 1. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
    Kim JW, Kim YY, Lee H, Park SH, Kim SK, Choe JY.
    J Rheumatol; 2017 Nov; 44(11):1674-1679. PubMed ID: 28864645
    [Abstract] [Full Text] [Related]

  • 2. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
    Eo DR, Lee MG, Ham DI, Kang SW, Lee J, Cha HS, Koh E, Kim SJ.
    J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV, Krema H, Hammoudi DS, Lipton JH, Simpson ER, Boyd S, Easterbrook M.
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [Abstract] [Full Text] [Related]

  • 7. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [Abstract] [Full Text] [Related]

  • 8. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [Abstract] [Full Text] [Related]

  • 9. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
    Bulut M, Akıdan M, Gözkaya O, Erol MK, Cengiz A, Çay HF.
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
    [Abstract] [Full Text] [Related]

  • 10. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O, Uchida A, Singh RP, Beven L, Hu M, Kaiser S, Srivastava SK, Ehlers JP.
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [Abstract] [Full Text] [Related]

  • 11. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y, Dysli C, Möller B, Wolf S, Zinkernagel MS.
    Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):2165-2172. PubMed ID: 31108547
    [Abstract] [Full Text] [Related]

  • 12. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
    Sauer L, Calvo CM, Vitale AS, Henrie N, Milliken CM, Bernstein PS.
    Ophthalmol Retina; 2019 Oct 01; 3(10):814-825. PubMed ID: 31345727
    [Abstract] [Full Text] [Related]

  • 13. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
    Adam MK, Covert DJ, Stepien KE, Han DP.
    Br J Ophthalmol; 2012 May 01; 96(5):723-9. PubMed ID: 22328813
    [Abstract] [Full Text] [Related]

  • 14. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
    Agarwal P, Wong YH, Dasgupta E, Agarwal R, Livingstone BI, Ramamurthy S, Chyn GS.
    Cutan Ocul Toxicol; 2015 May 01; 34(3):179-84. PubMed ID: 25068998
    [Abstract] [Full Text] [Related]

  • 15. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
    Lee MG, Kim SJ, Ham DI, Kang SW, Kee C, Lee J, Cha HS, Koh EM.
    Invest Ophthalmol Vis Sci; 2014 Nov 25; 56(1):396-402. PubMed ID: 25425304
    [Abstract] [Full Text] [Related]

  • 16. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
    Debellemanière G, Flores M, Tumahai P, Meillat M, Bidaut Garnier M, Delbosc B, Saleh M.
    Acta Ophthalmol; 2015 Nov 25; 93(7):e534-40. PubMed ID: 25989823
    [Abstract] [Full Text] [Related]

  • 17. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
    Motarjemizadeh Q, Aidenloo NS, Abbaszadeh M.
    Glob J Health Sci; 2015 Jun 25; 8(3):59-64. PubMed ID: 26493438
    [Abstract] [Full Text] [Related]

  • 18. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
    Martín-Iglesias D, Artaraz J, Fonollosa A, Ugarte A, Arteagabeitia A, Ruiz-Irastorza G.
    Lupus; 2019 Apr 25; 28(4):555-559. PubMed ID: 30755141
    [Abstract] [Full Text] [Related]

  • 19. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST, Jung JY, Zambrowski O, Pichi F, Su D, Arya M, Waheed NK, Duker JS, Chetrit Y, Miserocchi E, Giuffrè C, Kaden TR, Querques G, Souied EH, Freund KB, Sarraf D.
    Br J Ophthalmol; 2019 Nov 25; 103(11):1600-1604. PubMed ID: 30819690
    [Abstract] [Full Text] [Related]

  • 20. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
    Jeltsch BM, Sarraf D, Madjdpour D, Hanson JVM, Pfiffner FK, Koller S, Berger W, Barthelmes D, Al-Sheikh M.
    Retin Cases Brief Rep; 2024 May 01; 18(3):351-354. PubMed ID: 36857194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.